McKesson and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit
The Woodlands, Texas (February 2, 2017) — Representatives from McKesson and The US Oncology Network (The Network) will be presenting at the 10th Cancer Center Business Summit, which will be held Monday and Tuesday, February 6-7 at The Aria Resort in Las Vegas, Nevada. The Summit aims to showcase innovative organizations and how they are responding to changes occurring in the cancer care marketplace.
“Today’s community oncology practices face many decisions and challenges, from new reimbursement structures to care models and technologies,” said Randy Hyun, senior vice president and general manager, Provider Solutions, McKesson. “With these decisions come immense opportunities, and the Summit provides an important forum for discussion and knowledge-sharing. We are thrilled to have several panelists, representing multiple disciplines, participate in this year’s Summit. Our team will share their unique perspectives and insights on how organizations can remain independent in today’s consolidating landscape to best practices across a variety of important subjects, including clinical pathways and the use of big data.”
Marcus Neubauer, MD, vice president and medical director, Payer and Clinical Services, McKesson and The US Oncology Network, will participate in the Summit’s “Clinical Pathways: With What Result?” panel and discuss The Network’s experience with the Oncology Care Model (OCM) as it relates to clinical pathways. The OCM is a payment initiative introduced by the Centers for Medicare & Medicaid Services (CMS) to support the transition to value-based care. Dr. Neubauer will outline how practices can be successful under OCM and how adherence to clinical pathways will remain a cornerstone for value-based care. He will also provide real-world knowledge garnered from more than a decade of The Network’s experience with clinical pathways and, more recently, the OCM.
“The incorporation of clinical pathways is an important component for success in the OCM and other value-based care models,” said Dr. Neubauer. “The ability to transform and meet program requirements, provide enhanced services, and negotiate agreements with payers that support these aligned incentives all play critical roles in a practice’s performance and need to work in unison. We welcome the opportunity to share key learnings from our experience with value-based reimbursement models as we all strive to navigate today’s ever-changing cancer care landscape.”
Representatives from McKesson and members of The Network will participate in Summit panels discussing a broad spectrum of topics affecting the ecosystem of oncology practices, including value-based care and OCM, use of health technology and data, and important considerations for sustainable business models in today’s consolidating market. In addition, specialists in the areas of Merit-based Incentive Payment System (MIPS) and the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) will be on hand to discuss the latest trends and demands on practice leaders in the area of reimbursement.
Presenters from McKesson and The US Oncology Network include:
- Randy Hyun, senior vice president and general manager, Provider Solutions, McKesson will participate in the Summit’s “Remaining Independent: Achieving Scale through Practice Mergers & Collaborative Networks” panel discussion.
- Diana Verrilli, senior vice president, Payer and Practice Management Solutions, McKesson will join the discussion on “The Oncology Care Model: Evolving Best Practices.”
- Marcus Neubauer, MD, vice president and medical director, Payer and Clinical Services, McKesson and The US Oncology Network will participate in the “Clinical Pathways: With What Result?” panel.
- Debra Patt, MD, MPH, MBA, vice president of Public Policy and Academic Affairs at Texas Oncology and chair of The US Oncology Network Pathways Taskforce for Breast Cancer and editor in chief of ASCO’s JCO Clinical Cancer Informatics, is slated to participate in the Summit’s “Big Data Platforms to Support Community Oncology” panel.
- J. Russell Hoverman, MD, PhD, vice president of Quality Programs at Texas Oncology and medical director of Managed Care for McKesson and The US Oncology Network will share his perspective on palliative care solutions during a session of the same name.
The above panelists and other subject matter experts will be available in the McKesson exhibit space during the Summit. Additional information about the programs featured during the Summit can also be found at www.mckesson.com and www.usoncology.com.
About The US Oncology Network
Every day, The US Oncology Network helps more than 1,400 independent physicians deliver value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides doctors with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson. This collaboration allows the doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Together, The Network and its affiliated physicians are committed to the success of independent practices, everywhere. For more information, visit www.usoncology.com.
McKesson Corporation, currently ranked 6th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.
GCI Health on behalf of McKesson